[Pharmacotherapy of chronic obstructive pulmonary disease in patients with indications for long-term home oxygen therapy].
The authors submit a cross-sectional analysis of out-patient pharmacotherapy of chronic obstructive lung disease in 138 patients where long-term home oxygen therapy was indicated. To this group of patients no inhalatory bronchodilatating drugs were administered in 19.6% of the patients! The authors provide evidence of a non-significant better survival of patients who used inhalatory bronchodilatating drugs. From the mentioned group during the follow up period 41 (29.7%) died with a mean survival of 16.5 +/- 11.9 (0-39) months. Based on the mentioned results the authors draw attention to the relatively late indication of long-term home oxygen therapy and also to the fact that pharmacotherapy of patients with chronic obstructive lung disease indicated for long-term home oxygen therapy is not fully exploited and its optimalization could lead to better patient survival.
Rozborilová
E
E
Klinika tuberkulózy a pĺúcnych chorôb Jesseniovej lekárskej fakulty, Martinskej fakultnej nemocnice Martin, Slovenská republika.
Vysehradský
R
R
Strapko
P
P
Krivcíková
K
K
D000280:Administration, Inhalation; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D005260:Female; D006699:Home Care Services; D006801:Humans; D008297:Male; D008875:Middle Aged; D010102:Oxygen Inhalation Therapy; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy; D012189:Retrospective Studies
D001993:Bronchodilator Agents